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Abstract
Importance—The association of rare copy number variants (CNVs) with complex disorders is 
almost exclusively evaluated using clinically ascertained cohorts. As a result, the contribution of 
these genetic variants to cognitive phenotypes in the general population remains unclear.
- To investigate the clinical features of genomic disorders in adult carriers without clinical 
pre-selection.
- To assess the genome-wide burden of rare CNVs on carriers’ educational attainment and 
intellectual disability prevalence in the general population.
Design, Setting, and Participants—The population biobank of Estonia (EGCUT) contains 
52,000 participants, or 5% of the Estonian adults, enrolled in 2002-2010. General practitioners 
examined participants and filled out a questionnaire of health- and lifestyle-related questions, as 
well as reported diagnoses. As EGCUT is representative of the country's population, we 
investigated a random sample of 7877 individuals for CNV analysis and genotype-phenotype 
associations with education and disease traits.
Main Outcomes and Measures—Phenotypes of genomic disorders in the general population, 
prevalence of autosomal CNVs, and association of the latter variants with decreased educational 
attainment and increased prevalence of intellectual disability.
Results—We identified 56 carriers of genomic disorders. Their phenotypes are reminiscent of 
those described for carriers of identical rearrangements ascertained in clinical cohorts. We also 
generated a genome-wide map of rare (frequency ≤0.05%) autosomal CNVs and identified 10.5% 
of the screened general population (n=831) as carriers of CNVs ≥250kb. Carriers of deletions 
≥250kb or duplications ≥1Mb show, compared to the Estonian population, a greater prevalence of 
intellectual disability (P=0.0015, OR=3.16, (95%CI: 1.51-5.98); P=0.0083, OR=3.67, (95%CI: 
1.29-8.54), respectively), reduced mean education attainment (a proxy for intelligence; 
P=1.06e-04; P=5.024e-05, respectively) and an increased fraction of individuals not graduating 
from secondary school (P=0.005, OR=1.48 (95%CI: 1.12-1.95); P=0.0016, OR=1.89 (95%CI: 
1.27-2.8), respectively). The deletions show evidence of enrichment for genes with a role in 
neurogenesis, cognition, learning, memory and behavior. Evidence for an association between rare 
CNVs and decreased educational attainment was confirmed by analyses in adult cohorts of Italian 
(HYPERGENES) and European American (Minnesota Center for Twin and Family Research) 
individuals, as well as in the Avon Longitudinal Study of Parents and Children (ALSPAC) birth 
cohort.
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Conclusions and Relevance—Our results challenge the assumption that carriers of known 
syndromic CNVs identified in population cohorts are asymptomatic. They also indicate that 
individually rare but collectively common intermediate-size CNVs contribute to the variance in 
educational attainment. Refinements of these findings in additional population groups is warranted 
given the potential implications of this observation for genomics research, clinical care, and public 
health.
Keywords
genomic disorders; CNV; 16p11.2; population biobanks; education; intelligence; EGCUT; 
ALSPAC
Introduction
Recent studies showed that two human individuals differ on approximately 0.8% of their 
genome1. The Database of Genomic Variants catalogs ~2.4 million DNA copy number 
variants (CNVs), i.e. stretches of DNA that display altered copy-numbers, mapping to 
~200,000 unique loci that cover 72% of the human genome2. With such an extent of 
genomic sequences concerned, CNVs contribute to inter-individual variation3-6. Large 
recurrent CNVs were found to be associated with complex disorders, particularly 
developmental delay and intellectual disability7,8 characterized by limited intellectual 
functioning and impaired adaptive behavior in everyday life. These CNVs are listed in 
DECIPHER, a database for genomic variants and phenotypes in humans9 and are often 
regrouped under the term “genomic disorder”8.
Since associations of large rare CNVs with pathologies were almost exclusively evaluated 
using clinically ascertained, often pediatric, cohorts, it is unclear whether these structural 
variants affect health in the general adult population. For example, the reports of seemingly 
asymptomatic (reviewed in10), but not fully evaluated, control individuals and transmitting 
parents underscored their possible incomplete penetrance. Here we investigated the 
phenotypic profiles of adult carriers of known pathological CNVs who were not clinically 
pre-selected and assessed the burden of rare intermediate-size autosomal CNVs on 
educational attainment and intellectual disability.
Methods
EGCUT cohort
The Estonian Genome Centre of the University of Tartu (EGCUT) cohort is a population 
biobank containing 5% of the Estonian adult population11. Samples have been collected in 
all 15 Estonian counties and diverse social groups by 454 general practitioners (GPs; i.e. 
56% of the GPs in the registry of the Estonian Health Board). The age, sex and geographical 
distribution of the 52,000 participants closely reflect those of the Estonian adult population. 
The detailed description of the EGCUT cohort was previously published 11. At baseline, 
GPs performed a standardized objective examination of the participants and filled out a 
questionnaire that encompassed >1000 health- and lifestyle-related questions, as well as 
provided the diagnoses of diseases present in the medical history of the participating 
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individual using the format of the WHO international classification of diseases (WHO 
ICD-10)11 (see details in eMethods). The data are continuously updated through periodic 
linking to national electronic health registries. The wide range of phenotypes, ages and 
social groups makes the cohort ideally suited to population-based studies. See eFigure 1 and 
eMethods for details on the EGCUT phenotype data. EGCUT is conducted according to the 
Estonian Human Genes Research Act and managed in conformity with the standard ISO 
9001:2008. The Ethics Review Committee on Human Research of the University of Tartu 
approved the project. Written informed consent was obtained from all participants for the 
baseline and follow-up investigations.
The relevant phenotype traits of EGCUT individuals identified as carriers of DECIPHER-
listed syndromic CNVs (eTable 1) were obtained from the baseline questionnaire and 
compared with the reviewed characteristics of corresponding syndromes (eTable 2). To 
further investigate the clinical features of adult carriers not clinically pre-selected, we 
invited back all 16p11.2 600kb BP4-BP5 (breakpoint) deletion and reciprocal duplication 
carriers identified in EGCUT for follow-up investigations. These CNVs were selected 
because of their relatively high prevalence and variable phenotype. These carriers were 
phenotyped using the standardized clinical and neuropsychological protocol we developed 
previously to specifically study 16p11.2 syndrome patients ascertained through clinical 
cohorts10,12. In agreement with the known population prevalence of 16p11.2 600kb BP4-
BP5 CNVs12, we identified 4 deletion (0.05%) and 7 duplication carriers (0.09%) in the 
EGCUT set.
The EGCUT cohort (and Estonian population in general) is an outbred population with no 
substantial regional or ethnic differences. SNP allele frequencies and linkage disequilibrium 
patterns are similar to those found in populations with European ancestry13. We did not find 
small series of non-recurrent CNVs and/or inflation of recurrent rearrangements typical of 
founder effects14,15 (eMethods). Accordingly, EGCUT samples have been successfully 
used to discover or replicate hundreds of SNP associations, which are vulnerable to 
population frequencies and stratification differences (e.g.16-18). See eMethods and eFigure 
2 for details on the Estonian population makeup and stratification.
CNV calling—The genomic DNA of 8110 subjects (7020 for discovery and 1090 for 
replication cohort; eTable 3), randomly selected among the 52,000 EGCUT participants, 
was subjected to CNV analysis. A third cohort of 1066 individuals (“high-functioning 
replication cohort”) was used to further assess the significance of the signal obtained 
regarding education attainment. SNP-genotyping and CNV calling were performed using 
Illumina platforms and the Hidden Markov Model-based software PennCNV according to 
the manufacturer's and developer's protocols 19, respectively. The 6819 discovery, 1058 
replication and 993 “high-functioning” replication samples that passed the quality control 
parameters were retained (see eMethods for details).
Genotype-phenotype correlations—We analyzed the difference of studied phenotypes 
between CNV carriers and population. A two-sided Fisher's exact test and Welch two-
sample t-test were used for statistical analysis in The R Project for Statistical Computing 
environment (http://www.r-project.org, R version 3.0.2). Odds ratios (OR), 95% confidence 
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intervals and P-values were calculated; a threshold of P≤0.05 was set to indicate statistical 
significance. See eMethods for assessment of phenotype and determination of the 
prevalence of recurrent genomic syndromes. Briefly, intellectual disability (F70-79 of the 
WHO ICD-10) is defined in the DSM-IV as a deficit in overall cognitive functioning along 
with limitations in adaptive behavior. All diagnoses, including intellectual disability, were 
diagnosed according to diagnostic standards throughout the participant medical history and 
reported to the EGCUT database by the participant's GP at the moment of recruitment. 
Intellectual disability prevalence is estimated at 1-3% in developed countries20, which is 
consistent with the prevalence found in the EGCUT discovery cohort (1.7%).
Education levels were uniformly coded at the time of enrollment according to the Estonian 
education curriculum from 1 to 7, i.e. from less than primary school to scientific degree, 
respectively (details in eMethods). In both discovery and replication cohorts the mean 
education attainment (MEA) corresponded to secondary education (MEA=4.09 and 4.0, 
respectively) in agreement with the country's MEA. See eMethods for details on the 
Estonian population religiousness, school curriculum organization and education system 
performance.
Function of CNV-embedded genes—We used three previously published datasets to 
functionally annotate genes embedded in rare CNVs and assess if we could use those 
characteristics to predict CNV deleteriousness (eMethods): (i) the neurodevelopmental gene 
list21,22; (ii) the haploinsufficiency scores (HiS), i.e. the probability that a given gene 
maintains its normal function with only one functional copy23, and (iii) the list of ohnologs, 
i.e. paralogous genes resulting from ancestral whole-genome duplication events24. Since a 
CNV may preserve a gene's integrity yet indirectly affect it through changes in the copy-
number of its regulatory elements4,5,25, we also tested the potential contributions of the 
latter by stratifying CNVs using the number of encompassed regulatory elements identified 
in 26 (eMethods). To further assess the functions of imbalanced genes we used Thomson 
Reuters MetaCore™, an integrated software suite for data-mining and pathway analysis 
based on a manually-curated biological knowledge database (eMethods).
ALSPAC cohort
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort based in 
Bristol, UK 27. 14,541 pregnant women with expected delivery dates between 1st April 1991 
and 31st December 1992 were initially enrolled. 13,988 children who were alive at 1 year of 
age, and additional families were enrolled in later phases. Detailed phenotypic information 
on the children and their parents were collected during clinic visits and by completion of 
questionnaires, as well as from linkage with external data sources (eMethods). Ethical 
approval for the study was obtained from the ALSPAC Ethics and Law Committee and the 
Local Research Ethics Committees.
The Illumina HumanHap550 Quad platform was used to genotype 9912 children in 
ALSPAC. CNVs were called with PennCNV19. After quality control (eMethods), the subset 
of 5218 unrelated individuals with education information were retained for analysis (eTable 
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3). Log R Ratio (LRR) and B Allele Frequency (BAF) metrics were derived from raw data 
using published guidelines 28.
Within ALSPAC, educational attainment was assessed using data from the UK-based Key 
Stage 3 National Curriculum Tests in English and Mathematics, taken at age 13-14 years, 
also known as Standard Assessment Tests (SATs). A discrete level is awarded for these 
tests, but to further account for i) the exact mark received, and ii) the fact that the maximum 
and minimum level achievable for Mathematics was dependent upon the tier of examination 
for which the child was entered, results were scaled and adjusted as described 
previously 29,30. Due to non-normal distribution of the data, these two variables were then 
inverse-rank normal transformed, and then standardized. Furthermore, tertiles of the 
untransformed English and Mathematics scores were created (eTable 4). Differences in 
means of educational attainment according to rare CNV carrier status (frequency ≤0.05%) 
were compared using a Welch two-sided t-test. This was performed separately for each of 
the inverse-rank transformed, standardized English and Mathematics educational attainment 
scores. To obtain an interpretable estimate of effect univariable logistic regression models 
were assessed separately for English and Mathematics. The top tertile was coded as the 
reference group, and the bottom tertiles as the risk group. Separate odds ratios were 
estimated for membership of the risk group, comparing CNV carriers corresponding to 
increasing size groups against baseline (no large CNVs at a given frequency, 0.0005). The 
binary educational outcome was then regressed against CNV carrier status as an ordered 
variable, including all four size-categories, and the P value was reported as an assessment of 
trend.
MCTFR cohort
Participants from two studies conducted by the Minnesota Center for Twin and Family 
Research (MCTFR) were used as replication samples: the Sibling Interaction and Behavior 
Study (SIBS), and the Minnesota Twin Family Study (MTFS). MTFS is a longitudinal study 
of a community-based sample of same-sex twins born between 1972 and 1994 in the State of 
Minnesota (USA) and their parents 31. SIBS is an adoption study of sibling pairs and their 
parents32; its community-based sample contains families where both siblings are adopted, 
where both are biologically related to the parents, or where one is adopted and one is 
biologically related. In the current analyses, only a single random individual was selected for 
inclusion in analyses in order to create a dataset of unrelated participants (n=2390, eTable 
3). The collection, genotyping, and analysis of DNA samples for both studies were approved 
by the University of Minnesota Institutional Review Board's Human Subjects Committee. 
Written informed assent or consent was obtained from all participants; parents provided 
written consent for their minor children.
Genotyping was performed using the Illumina 660W-Quad array. Whole-blood extracted 
DNA samples were only analyzed if the participant was i) white non-Hispanic and the 
standard deviation of the GC-corrected 33 autosomal log R ratios was less than 0.20. CNVs 
were called using PennCNV and then processed and filtered. Adjacent CNVs were merged 
if they had the same copy number and if the number of markers in the intervening gap was 
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less than 20% of the number of total markers spanning the called CNVs. Rare (frequency 
≤0.05%) deletions ≥250kb and duplications ≥1Mb were retained in the burden analysis.
Full-Scale IQ (FSIQ) was estimated using an abbreviated form of either the Wechsler 
Intelligence Scale for Children-Revised (WISC-R; for children 16 years and younger) or the 
Wechsler Adult Intelligence Scale-Revised (WAISR; for individuals older than 16). The 
short forms consisted of two Performance subtests (Block Design and Picture Arrangement) 
and Verbal subtests (Information and Vocabulary) and were prorated to determine FSIQ. 
Estimates from this short form have been shown to correlate 0.94 with FSIQ from the 
complete test 34. Samples with multiple FSIQ measurements were averaged together for 
analysis (mean=104.52±14.27; range=67-150).
Italian HYPERGENES cohort
The Italian follow-up is based on 451 individuals belonging to the cohort ascertained as 
controls for genome-wide association studies of hypertension (HYPERGENES)35 (eTable 
3). Years of Schooling were defined in accordance with the ISCED 1997 classification, 
leading to seven categories of educational attainment that are internationally comparable 
(see details in eMethods). SNPs were genotyped using Illumina Human 1M-Duo BeadChips 
and CNVs called with PennCNV as for the discovery cohort. Differences in means of 
educational attainment were compared using a Welch two samples one-tailed t-test and 
Wilcoxon rank-sum test in R. Both tests returned comparable results.
Results
Prevalence and phenotypes of pathological CNVs in EGCUT
To investigate the medical burden of rare CNVs in the general population we opted for a 
genotype-first approach and analyzed a random sample cohort from EGCUT. Within a 
combined discovery and replication sample of 7877 unrelated individuals, we identified 56 
carriers of known recurrent autosomal genomic disorders (0.7%; eTable 1). While the 
prevalence of each genomic disorder is lower than previously reported in clinical 
cohorts36,37, it is only slightly lower than the 67 individuals expected according to the 
reported population prevalence of the 57 autosomal syndromes listed in the DECIPHER 
database of genomic disorders9 (eTable 2, eTable 5 and eMethods). EGCUT is depleted (6 
observed carriers/17 expected, P=0.03, OR=0.35, CI95%(0.11; 0.94)) of the most 
deleterious CNVs (graded 1-2 by DECIPHER), while the frequency of CNVs graded 3 and 
ungraded is as expected (50/50, P=1, OR=1, CI95%(0.66; 1.51)).
The clinical features of EGCUT carriers of DECIPHER-listed CNVs are comparable to 
those reported in disease cohorts. 31 (55%; including only formal diagnosis) and 39 out of 
56 (70%; including self-reported problems) carriers recruited from the general population 
with no prior awareness of their genetic disorder present phenotypes previously associated 
with their genomic lesion in the literature (see eTable 1 for the phenotypes identified in the 
56 EGCUT carriers and eTable 2 for phenotypes associated with DECIPHER-listed CNVs). 
For example, carriers of the 16p11.2 600kb BP4-BP5 deletions and reciprocal duplications 
identified in clinical cohorts show opposite phenotypes on body weight, head size and 
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volume of specific cortico-striatal structures. They exhibit reduced full-scale intellectual 
quotient (FSIQ), as well as neuro-psychiatric problems and congenital 
abnormalities10,12,38-44. Correspondingly, the baseline questionnaires of the 4 deletion 
(cases no 41-44 in eTable 1) and 7 duplication (no 45-51) carriers identified in EGCUT 
indicated high and low body mass indexes, respectively, as well as neuropsychiatric traits, 
learning and developmental problems. The follow-up evaluation of these carriers uncovered 
additional similarities in the spectrum and severity distribution of phenotypic features found 
in 16p11.2 BP4-BP5 rearrangement carriers identified through pan-European recruitment 
via clinical genetics center (eTable 6).
Rare intermediate size CNVs and educational attainment
We then generated the genome-wide map of rare autosomal CNVs in the discovery set of 
6819 individuals (eTable 3) and identified a total of 216 deletion and 509 duplication 
carriers (≥250kb with carrier frequency ≤0.05%; eTable 7). The underrepresentation of 
deletions compared to duplications (P=2.2e-16) is consistent with previous reports and 
concordant with the hypothesis that the former are more deleterious1,14. We found evidence 
for an association between carrier status and prevalence of intellectual disability (3.2% 
(n=23) in rare CNV carriers vs 1.7% (n=114) in EGCUT; P=0.007, OR=1.93 (95%CI: 
1.17-3.06)). This effect was mainly driven by deletions (5.1% of intellectual disability, 
n=11; P=0.0015; OR=3.16 (95%CI: 1.51-5.98)) and remained even after exclusion of 
carriers of DECIPHER-listed CNVs (2.8% n=19; P=0.05, OR=1.64 (95%CI: 0.95-2.71), 
8.9% of which were diagnosed with intellectual disability (n=4, P=0.0072, OR=5.74 
(95%CI: 1.47-16.22)).
We next assessed the correlation between CNV size and intellectual disability, as it was 
previously reported that in comparison to controls, cohorts of affected patients show an 
excess of CNVs and that this excess is larger for longer CNVs7. The frequency of 
intellectual disability increases with CNV size (4.3% (n=6, P=0.033, OR=2.65 (95%CI 
0.94-6.11)) in 250-500kb versus 8.3% for ≥1Mb deletions (n=36, P=0.023, OR=5.34 
(95%CI: 1.03-17.42)), while associations with duplications are only detectable when 
rearrangements exceed 1Mb in size (5.9% n=102; P=0.0083, OR=3.67; (95%CI: 1.29-8.54); 
Table 1). Smaller deletions (125kb≤CNV<250kb; n=275) had no apparent impact on this 
prevalence (2.5% (n=7, P=0.24, OR=1.5 (95%CI: 0.59-3.28)).
The diagnosis of intellectual disability is binary; thus to assess with greater granularity the 
effect of rare CNVs, we investigated if their occurrence and size are related to achieved 
education levels, a proxy for global cognition45,46. For this purpose we used the scale of 
seven sublevels of the Estonian education curriculum (eMethods). While 25.3% (n=1729) 
of sampled EGCUT individuals fail to complete secondary school (level 4; EGCUT mean 
education attainment (MEA)=4.09, similar to the Estonian population11), this proportion is 
higher in carriers of DECIPHER-listed genomic disorders with 48.9% (n=22) of them only 
reaching elementary or basic education (P=0.0008, OR=2.8 (95%CI: 1.49-5.3); MEA=3.71, 
P=0.028; Figure 1). The fraction of carriers that fail to reach secondary education increases 
with CNV size (e.g. ≥1Mb CNV carriers have a MEA=3.65 (P=4.6e-07) and 40.6% (n=56) 
of them do not complete secondary school (P=0.0001, OR=2.01 (95%CI: 1.40-2.87)); 
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Figure 1). Deletions are responsible for the bulk of the outcome with MEA decreasing to 
3.5 (P=0.0004) and 47.2% (n=17) of 1Mb deletion carriers not completing secondary 
education (P=0.006, OR=2.63 (95%CI: 1.28-5.36); Figure 1). A decrease is already seen in 
the 250-500kb CNV carrier group with MEA=3.86 (P=0.017) and 29.5% (n=41) of carriers 
not graduating from secondary school (P=0.28, OR=1.23 (95%CI: 0.83-1.80)). In agreement 
with the intellectual disability results, smaller deletions (125kb≤CNV<250kb: n=275) were 
not associated with changes in education attainment (MEA=4.11 (P=0.80), less than 
secondary education 26.2% (n=72, P=0.78, OR=1.04 (95%CI: 0.78-1.38))), while 
duplications were associated only with rearrangements ≥1Mb (MEA=3.71; P=0.00015 and 
38.2% (n=39) of carriers failing to complete secondary school; P=0.0042, OR=1.82 (95%CI: 
1.19-2.77); Figure 1).
EGCUT ancestry principal components are not associated with CNV burden (eFigure 2), 
indicating that genetic stratification is likely not confounding the association with 
educational attainment. Likewise, differences in education possibilities due to religion or 
ethnicity could not account for the observed associations as the OECD “Program for 
International Student Assessment” and “for International Assessment of Adult 
Competencies” surveys showed that the “free education for all” Estonian system is among 
the best in the world in term of results and equal opportunity (eMethods).
Estonian replication
We conducted a replication of the education analysis on a non-overlapping random set of 
1058 unrelated EGCUT individuals recruited similarly (eTable 3), but sampled at a different 
time-point and genotyped using a different array platform (replication cohort: MEA=4.00, 
25.6% (n=271) failing to complete secondary school). In agreement with the discovery 
cohort, we noted a diminished education attainment in 250kb≤CNV<500kb deletion carriers 
(MEA=3.68, P=0.056; 36% (n=9) with only basic education or less, P=0.25, OR=1.63 
(95%CI: 0.63-3.98)) and ≥1Mb duplication carriers (MEA=3.54, P=0.15; 46.2% (n=6), 
P=0.11, OR=2.49 (95%CI: 0.68-8.72). The joint analyses of these two random cohorts 
confirmed the negative effect of rare deletions ≥250kb (MEA=3.81; P=1.06e-04; less than 
secondary 33.5% (n=83); P=0.005, OR=1.48 (95%CI: 1.12-1.95) and duplications ≥1Mb 
(MEA=3.69; P=5.024e-05; less than secondary 39.1% (n=45); P=0.0016, OR=1.89 (95%CI: 
1.27-2.8) on educational attainment (see full details in Figure 1 and Table 2). To challenge 
our results further, we then used a non-overlapping set of 993 unrelated individuals that, due 
to different ascertainment criteria (eTable 3 and eMethods), were biased towards higher 
than average socio-cognitive functioning (high-functioning replication cohort: MEA=4.77, 
lower than secondary education 9.4% (n=93)). Even in this group that is probably partially 
depleted of severe impact CNVs, we observe a lowering of the MEA of 250kb≤CNV<500kb 
deletion and ≥1Mb duplication carriers of the same order of magnitude (MEA=4.36, Δ=
−0.41 and 4.44, Δ=−0.33, respectively). Combining both independent replication cohorts 
confirmed our results (replication cohorts MEA=4.36; 250kb≤CNV<500kb deletion carriers 
MEA=3.91 (P=0.004); ≥1Mb duplication: MEA=3.79 (P=0.057)); the same holds true if all 
three Estonian cohorts were analyzed together (eTable 8).
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ALSPAC, HYPERGENES and MCTFR follow-up
We sought to strengthen the inference from our results using the ALSPAC birth cohort and 
SATs scores at the age of 13-14 years as an alternative measure of education attainment 
(n=5218; eTable 3). When mean education attainment was studied using the transformed 
variables, Mathematics scores were decreased in carriers of rare intermediate-size deletions 
compared to controls (250kb≤CNV<500kb: Welch two-sided t-test comparing means 
P=0.019), and English scores were decreased in carriers of large deletions (≥1Mb, Welch 
two-sided t-test comparing means P=0.020)(eTable 9). Mean educational attainment in 
English and Mathematics was decreased in those who carried large duplications (≥1Mb; 
P=0.020 and P=0.049 respectively, Welch two-sided t-test). These results confirm the 
association between education attainment and rare CNVs using a different education metrics 
in a geographically distinct and differently ascertained cohort of adolescents.
Larger CNV size increased the odds of individuals belonging to the lowest tertile of SATs 
score (compared to the top, reference tertile) for both English and Mathematics. This was 
apparent both for carriers of deletions (English: 250kb≤CNV<500kb, OR 1.26 [95%CI 0.81, 
1.95]; 500kb≤CNV<1Mb, OR 1.69 [95%CI 0.88-3.30]; ≥1Mb, OR 4.18 [95%CI 1.48, 
14.87]; trend [p=0.002]; Mathematics: 250kb≤CNV<500kb, OR 1.42 [95%CI 0.91, 2.21]; 
500kb≤CNV<1Mb, OR 2.21 [95%CI 1.01, 5.06]); ≥1Mb, OR 3.69 [95%CI 1.51, 10.29], 
trend [p=0.0002]) and duplications, albeit in this analysis, substantive evidence for an 
association of duplications and educational attainment was only observed for English results 
(English: 250kb≤CNV<500kb, OR 1.14 [95%CI 0.81, 1.61]; 500kb≤CNV<1Mb, OR 1.19 
[95%CI 0.76,1.87]; ≥1Mb, OR 2.22 [95%CI 1.07, 4.84]; trend [p=0.035]; Mathematics: 
250kb≤CNV<500kb, OR 1.10 [95%CI 0.78, 1.54]; 500kb≤CNV<1Mb, OR 1.03 [95%CI 
0.68, 1.55]; ≥1Mb, OR 1.54 [95%CI 0.80, 3.01]; trend [p=0.273]) (Table 3).
Our results were followed-up in two separate cohorts of healthy individuals with normal 
cognitive functioning (eMethods). Consistent with this ascertainment, both Italians and 
European Americans recruited for the HYPERGENES and MCTFR cohort, respectively, 
showed evidence of paucity of DECIPHER-listed CNVs [1 observed vs. 4 expected 
(P=0.37; OR=0.25, CI95% 0.005-2.53) and 14 vs. 20 (P=0.39, OR=0.7, 95%CI 0.32-1.46, 
respectively (eTable 2)]. Of note, the HYPERGENES analysis was restricted by small 
sample size (n=451; eTable 3) resulting in both a limited statistical power and limited CNV 
frequency calculation (≥0.25%). At this 5-fold higher level of prevalence, the MEA was 
reduced in carriers of deletion 500kb≤CNV<1Mb (ΔMEA=−0.26; P=0.39, Wilcoxon test) 
and the ≥1Mb duplications (ΔMEA=−0.66; P=0.11, Wilcoxon test)(eTable 10). A 
consistent, but similarly underpowered, decrease of FSIQ was found in MCTFR carriers of 
rare deletions (500kb≤CNV<1Mb: Δ=−4.23 IQ points, P=0.43; ≥1Mb: Δ=−13.82 IQ points, 
P=0.09) and duplications (500kb≤CNV<1Mb: Δ=−5.56, P=0.01; ≥1Mb: Δ=−6.03, P=0.16) 
(eTable 11).
Female mutation burden
In contrast to duplication carriers (male:female ratio=1.06 (303:285), we observe an excess 
of female carriers in every deletion size class ≥250kb separately and together within the 
combined Estonian discovery and replication cohort [M:F=0.78 (109:139); P=0.14, 
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OR=1.22 (95%CI: 0.94-1.59)]. Female deletion carriers also show a more severe decrease in 
MEA than males in EGCUT [Female MEA=4.13 vs. Female del 250kb≤CNV<500kb 
MEA=3.71 (P=0.0003); Male MEA=4.02 vs Male del 250kb≤CNV<500kb MEA=4.00 
(P=0.847); Figure 1). The joint analysis of the three Estonian cohorts confirmed that female 
deletion carriers are responsible for the majority of the decrease in education attainment 
(EGCUT combined female MEA=4.22, 250kb≤CNV<500kb deletion female MEA=3.71, 
P=3.9e-08; less than secondary education 20.3% (n=920), deletion female 33.6% (n=49), 
P=0.00024, OR=1.99 (95%CI: 1.37-2.85) (eTable 8). Consistent with the Estonian results in 
the MCTFR cohort deletions ≥500kb had a stronger effect on FSIQ in females (Δ=−13.73; 
P=0.03) compared to males (Δ=−0.12; p=0.98; eTable 11).
Assessment of CNV deleteriousness and function
Investigating the functions of the 642 protein-coding genes encompassed in the identified 
rare ≥250kb deletions, we found evidence of enrichment for genes with a role in 
neurogenesis, cognition, learning, memory and behavior (29 out of the top 50 GO processes 
with strongest evidence; all with FDR<2.45e-05; eTable 12). We then assessed if we could 
use gene characteristics to more accurately predict CNV deleteriousness. We stratified 
CNVs by the number of embedded i) protein-coding and non-coding genes, ii) 
neurodevelopmental (ND) genes22, iii) ohnologs24, or by iv) the sum of imbalanced genes’ 
probability score for haploinsufficiency (HiS)23, and v) the highest HiS in the CNV. A 
decrease of cognitive abilities was present in carriers of deletions encompassing ≥2 genes 
(MEA=3.82, P=0.003) and duplications including ≥11 genes (MEA=3.74, P=0.0003) 
(eFigure 3). When genes were present in the rearranged interval, deleteriousness was 
associated with the presence of at least one protein-coding gene (intellectual disability 
prevalence 5.3% (n=8), P=0.0046; OR=3.31 (95%CI: 1.37-6.93); MEA=3.79, P=0.0014; 
33.3% (n=50) not reaching secondary education, P=0.029, OR=1.47 (95%CI: 1.02-2.1) in 
agreement with the observation that the majority of Mendelian pathogenic mutations disrupt 
coding sequences 47. Prevalence of intellectual disability was best correlated with the 
presence of at least one ND-gene in the deleted interval (prevalence 8.8% (n=6), P=0.001, 
OR=5.69 (95%CI: 1.97-13.47); MEA=3.76, P=0.03) and the sum of HiS (Highest quartile of 
HiS sums: 8.9% (n=4), P=0.0072, OR=5.74 (95%CI: 1.46-16.22; MEA=3.91, P=0.27). 
Presence of an ohnolog in the deletion is associated with a higher prevalence of intellectual 
disability, however to a lesser degree (5.9% (n=6), P=0.008, OR=3.7 (95%CI: 1.29-8.54). 
Neither separately nor together did the numbers of promoters, enhancers, transcriptional 
elements and insulators within a CNV correlate with intellectual disability and educational 
attainment.
Discussion
While various large pathogenic CNVs are known, the vast majority of rare CNVs of 
intermediate size (250-500kb) were thought to be non-deleterious. In the current report we 
show that the presence of both recurrent syndromic and rare intermediate-size non-recurrent 
CNVs, which are cumulatively frequent in the general population (10.5%), correlates 
positively with prevalence of intellectual disability and negatively with educational 
attainment. Our results are likely to be underestimated through i) exclusion of the most 
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severely affected patients, ii) inclusion of patients with CNVs known to have no impact on 
cognition and iii) incorrect inclusion of carriers of large somatic/tumorigenic genomic 
lesions.
The link between impaired cognitive functioning and lower academic achievement in CNV 
carriers parallels the recognized correlation between health and education48. This health-
education gradient was postulated to result from the combination of i) heritable factors 
impacting both traits, ii) poor early-life health that affects learning, and iii) health-related 
behaviors being modulated by education. While recurrent CNVs conferring risk of autism 
spectrum disorders or schizophrenia were associated with a decrease in IQ of individuals 
from the general population49 and phenotype mining of carriers of genomic variants in the 
Northern Finland 1966 Birth Cohort revealed an excess of lower IQ, school grade retention 
before age 14 and impaired hearing among individuals carrying deletions >500kb previously 
implicated in neurodevelopmental disorders14, both studies failed to recognize that other 
CNVs, in particular non-recurrent ones, were also associated with decreases in cognitive 
capabilities.
Although 40-80% of the variance in intelligence and 20-40% in educational attainment are 
explained by genetic factors 50-53 studies failed to find major contributors to this heritability. 
For example, three individual SNPs each with an approximate effect size of one month of 
schooling per allele have been identified in a GWAS encompassing >126,000 individuals 
(largest estimated effect = 0.02%) 17 and only a polygenic model including ~300,000 
common SNPs genome-wide explained 28-29% of variation in general cognition 54. While 
earlier studies failed to identify common CNVs as major contributors to the above 
heritabilities 55-58, our results suggest that rare structural variants ≥250kb for deletions and 
≥1Mb for duplications are associated with complex social-science traits in population 
cohorts. About 2% of the analyzed biobank participants carry a rare CNV ≥1Mb. Even 
without considering other health problems, a fifth of them appear to be linked with 
decreased life quality as the fraction reaching secondary education level is lowered by 15% 
when comparing CNV carriers to the general population. This reduction results in a MEA 
that is half a level lower. If we add to this fraction of rare ≥1Mb CNVs both the smaller 
intermediate-size CNVs associated with decreased educational attainment identified in this 
report (at least 0.2% of the population), and the highly pathogenic anomalies absent from 
EGCUT (0.15%), the life quality of 1 of 40 people might be negatively affected by rare 
CNVs. These variants may account for a sizable portion of the heritability of the complex 
“educational attainment” measure52.
The observed excess of females carrying rare genomic deletions supports the recently 
described female-biased mutational burden 21,59. Females appear “protected” from 
neurodevelopmental disorders. This potentially allows females to be enrolled in general 
population cohorts despite the fact that they carry rare CNVs, while their male counterparts 
who likely present more severe phenotypes are excluded from such recruitment. 
Consequently and corroboratively, female deletion carriers mostly drove the signal on 
education attainment.
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While intellectual disability prevalence was increased with presence of a 
neurodevelopmental or ohnolog gene in the deleted interval or a high haploinsufficiency 
score of imbalanced genes, none of the assessed evaluators correctly capture the variation in 
education attainment, possibly because they are limited to protein-coding genes. 
Investigation of the function of the encompassed protein-coding genes revealed that they 
were enriched for genes involved in neurogenesis, cognition, learning, memory and 
behavior. This is consistent with the hypothesis that these rearrangements are rare because 
they impact genes important for neurodevelopment and thus are rapidly purged from the 
population.
While none of the carriers of known syndromic CNVs identified in EGCUT were previously 
diagnosed with a genetic disease, many suffered from major clinical problems (e.g. 
intellectual disability, congenital anomalies, neuropathies, neuropsychiatric disturbances, 
extreme obesity and reproductive problems). As the latter are most likely caused by the 
newly-found genetic alterations, it suggests that these individuals have escaped the attention 
of the medical genetics system and thus not received proper examination and counseling.
Conclusions
Our results suggest that population carriers of known syndromic CNVs identified in the 
general population are not asymptomatic. They also indicate that individually rare, but 
collectively common, intermediate-size CNVs negatively contribute to the variance in 
educational attainment. Validation of this finding in additional population groups is 
warranted given the potential implications of this observation for genomics research, clinical 
care, and public health.
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Figure 1. Rare intermediate-size CNVs are associated with decreased education metrics
The education attainment decreases with CNV size. The different panels compare the 
distribution of achieved education levels of the assessed general population (EGCUT) with 
carriers of DECIPHER-listed rearrangements (DECIPHER) or with carriers of CNVs 
(frequency ≤ 0.05%), deletions, deletion females and duplications segregated by size. 
Asterisks placed above the stacked columns specify different distributions, while the ones 
positioned at the boundary between basic and secondary education levels (levels 3 and 4, 
respectively) denote differences in the fraction of individuals who reached at least secondary 
education. P-values ≤ 0.05, ≤ 0.01 and ≤ 0.001 are indicated by *, ** and ***, respectively. 
The actual P-values are mentioned in the main text and Table 3. Education levels are coded 
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according to the Estonian education curriculum: 1 - less than primary; 2 - primary; 3 – basic; 
4 – secondary; 5 – professional higher/college; 6 – university/academic degree; 7 – scientific 
degree (see eMethods for details). Note that while 21.2% of EGCUT females (n=855) hold 
college or academic degrees, the presence of a rare deletion is associated with a decreased 
ability to achieve these highest education levels (del 250-499kb: 12.9% (n=12) of female 
with levels 5-7; P=0.05, OR=0.55 (95%CI:0.27-1.02)). For example, only one (a carrier of 
the 17p12 deletion causative for HNPP peripheral neuropathy, OMIM #162500) of 20 
females carrying deletions ≥1Mb reached an education level above secondary school.
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Table 1
Prevalence of intellectual disability diagnosis in EGCUT
Cohort Sample size Intellectual disability prevalence (nb of cases) OR (CI95%) P-value
EGCUT all samples 6819 1.7% (114)
DECIPHER CNV carriers 45 8.9% % (4)** 5.74 (1.47; 16.22) 0.0072
DEL carriers ≥ 1 Mb 36 8.3% (3)* 5.34 (1.03; 17.42) 0.023
DEL carriers ≥ 500 kb 77 6.5% (5)** 4.08 (1.26; 10.25) 0.01
DEL carriers ≥ 250 kb 216 5.1% (11)** 3.16 (1.51; 5.98) 0.0015
500 kb ≤ DEL carriers < 1 Mb 41 4.9% (2) 3.02 (0.35; 11.9) 0.1522
250 kb ≤ DEL carriers < 500 kb 139 4.3% (6)* 2.65 (0.94; 6.11) 0.0326
DUP carriers ≥ 1 Mb 102 5.9% (6)** 3.67 (1.29; 8.54) 0.0083
DUP carriers ≥ 500 kb 235 3.4% (8) 2.07 (0.86; 4.29) 0.066
DUP carriers ≥ 250 kb 509 2.4% (12) 1..42 (0.71; 2.6) 0.285
500 kb ≤ DUP carriers < 1 Mb 133 1.5% (2) 0.87 (0.11; 3.38) 1.0000
250 kb ≤ DUP carriers < 500 kb 274 1.5% (4) 0.87 (0.23; 2.32) 1.0000
Carriers of rare deletions are indicated as DEL and rare duplications as DUP. The results are presented as cumulative or as size-separated groups. 
DECIPHER CNV correspond to all CNV listed within the DECIPHER database (see text for details).
Significant results are highlighted in bold; P-values ≤ 0.05, ≤ 0.01 and ≤ 0.001 are pinpointed by *, ** and *** respectively.
1For both deletions and duplications, ‘Controls’ are those individuals carrying neither a deletion nor a duplication ≥250kb.
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